These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12925765)

  • 1. Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4.
    Venkatesan S; Rose JJ; Lodge R; Murphy PM; Foley JF
    Mol Biol Cell; 2003 Aug; 14(8):3305-24. PubMed ID: 12925765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional consequences of chemically-induced β-arrestin binding to chemokine receptors CXCR4 and CCR5 in the absence of ligand stimulation.
    Liebick M; Henze S; Vogt V; Oppermann M
    Cell Signal; 2017 Oct; 38():201-211. PubMed ID: 28733085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent.
    Signoret N; Hewlett L; Wavre S; Pelchen-Matthews A; Oppermann M; Marsh M
    Mol Biol Cell; 2005 Feb; 16(2):902-17. PubMed ID: 15591129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression.
    Venkatesan S; Petrovic A; Locati M; Kim YO; Weissman D; Murphy PM
    J Biol Chem; 2001 Oct; 276(43):40133-45. PubMed ID: 11514564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of CXCR4 and CCR5 endocytosis.
    Signoret N; Rosenkilde MM; Klasse PJ; Schwartz TW; Malim MH; Hoxie JA; Marsh M
    J Cell Sci; 1998 Sep; 111 ( Pt 18)():2819-30. PubMed ID: 9718374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors.
    Isik N; Hereld D; Jin T
    PLoS One; 2008; 3(10):e3424. PubMed ID: 18923649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
    Szabo I; Wetzel MA; Zhang N; Steele AD; Kaminsky DE; Chen C; Liu-Chen LY; Bednar F; Henderson EE; Howard OM; Oppenheim JJ; Rogers TJ
    J Leukoc Biol; 2003 Dec; 74(6):1074-82. PubMed ID: 12972507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways.
    Blanpain C; Wittamer V; Vanderwinden JM; Boom A; Renneboog B; Lee B; Le Poul E; El Asmar L; Govaerts C; Vassart G; Doms RW; Parmentier M
    J Biol Chem; 2001 Jun; 276(26):23795-804. PubMed ID: 11323418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalization.
    Catusse J; Parry CM; Dewin DR; Gompels UA
    Blood; 2007 May; 109(9):3633-9. PubMed ID: 17209056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence, dominance, and possible decline of CXCR4 chemokine receptor usage during the course of HIV infection.
    Meehan CJ; Hedge JA; Robertson DL; McCormack GP; Travers SA
    J Med Virol; 2010 Dec; 82(12):2004-12. PubMed ID: 20981786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis.
    Lagane B; Ballet S; Planchenault T; Balabanian K; Le Poul E; Blanpain C; Percherancier Y; Staropoli I; Vassart G; Oppermann M; Parmentier M; Bachelerie F
    Mol Pharmacol; 2005 Jun; 67(6):1966-76. PubMed ID: 15761117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4.
    Wang J; Alvarez R; Roderiquez G; Guan E; Norcross MA
    J Cell Biochem; 2004 Nov; 93(4):753-60. PubMed ID: 15660419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage.
    Santos-Costa Q; Lopes MM; Calado M; Azevedo-Pereira JM
    Retrovirology; 2014 Nov; 11():99. PubMed ID: 25421818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization.
    Kraft K; Olbrich H; Majoul I; Mack M; Proudfoot A; Oppermann M
    J Biol Chem; 2001 Sep; 276(37):34408-18. PubMed ID: 11448957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
    Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor.
    Chelli M; Alizon M
    J Biol Chem; 2001 Dec; 276(50):46975-82. PubMed ID: 11600494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.
    Weitzenfeld P; Ben-Baruch A
    Cancer Lett; 2014 Sep; 352(1):36-53. PubMed ID: 24141062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.